期刊文献+

调整免疫抑制剂对肝移植感染全身炎症反应综合征的影响 被引量:2

Effects of Withdrawing Immunosuppressants on Inflammatory Indexes in Liver Transplantation Infection
原文传递
导出
摘要 目的探讨停用免疫抑制剂对肝移植感染炎症指标的影响。方法根据多器官功能障碍综合征(MODS)评分法对肝移植感染患者进行评分,当MODS 13~16分时停用免疫抑制剂(26例,停用组),观察患者体温、心率、呼吸和外周血白细胞的变化,并与感染未停用免疫抑制剂(13例,常规组)的患者比较。结果感染后,加强抗感染治疗或同时停用免疫抑制剂均可改善患者的体温、心率、呼吸和外周血白细胞(P<0.05),但同时停用免疫抑制剂则更利于体温、心率、呼吸和外周血白细胞的改善(P<0.05)。结论肝移植感染者,在加强抗感染治疗的基础上,同时停用免疫抑制剂更有利于控制感染。 OBJECTIVE To explore the effects of withdrawing immunosuppressants on the inflammatory indexes.METHODS Based on the MODS score,the infections of liver transplantation were scored.When the MODS scores reached 13-16,the immunosuppressants were withdrawn in 26 infectious cases(test group),and the patients′ temperatures,heart rates,breathing rates and white blood cells were recorded daily.All of them were compared to the previous no with drawing immuno group(13 cases,control group).RESULTS After making the definite diagnoses of infections and strengthening the anti-infection treatment,suppressants both two groups could normalize the patients′ temperatures,heart rates,breathing rates and WBC(P0.05);but the test group could do better(P0.05).CONCLUSIONS For the infection of liver transplantation,strengthening anti-infection treatment,and simultaneously,withdrawing immunosuppressants could do more favor for the infection control.
机构地区 解放军第
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第6期782-784,共3页 Chinese Journal of Nosocomiology
基金 总后勤部卫生部专项科研项目(174)
关键词 肝移植 感染 免疫抑制剂 炎症指标 Liver transplantation Infection Immunosuppressant Inflammatory index
  • 相关文献

参考文献6

二级参考文献40

共引文献23

同被引文献13

  • 1巫林伟,何晓顺,朱晓峰,马毅,王东平,邰强,鞠卫强,游燊,郭志勇,黄洁夫.肝移植术后真菌感染患者免疫抑制方案的调整[J].中华普通外科杂志,2007,22(9):647-649. 被引量:5
  • 2孙强,朱晓峰,何晓顺,廖海华,鞠卫强,巫林伟,邰强,黄洁夫.暂停免疫抑制剂对肝移植术后严重感染疗效的探讨[J].中华普通外科杂志,2007,22(9):650-652. 被引量:10
  • 3Echaniz A , Pita S,Otero A , et al . Incidence,risk factors andinfluence on survival of infectious complications in livertransplantation. Enferm Infect Microbiol Clin, 2003,21 :224-231.
  • 4Venkataramanan R,Shaw LM,Sarkozi L. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients[J].Journal of Clinical Pharmacology,2001.542-551.
  • 5Rovira P,Mascarell L,Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation[J].Current Medicinal Chemistry,2000.673-692.
  • 6Israeli M,Yussim A,Mor E. Preceeding the rejection:in search for a comprehensive post-transplant immune monitoring platform[J].Transplant Immunology,2007.7-12.
  • 7Israeli M,Klein T,Sredni B. ImmuKnow:a new parameter in immune monitoring of pediatric liver transplantation recipients[J].Liver Transplantation,2008.893-898.
  • 8Bhorade SM,Janata K,Vigneswaran WT. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection[J].Journal of Heart and Lung Transplantation,2008.990-994.
  • 9Pérez-Flores I,Sánchez-Fructuoso A,Santiago JL. Intracellular ATP levels in CD4 + lymphocytes are a risk marker of rejection and infection in renal graft recipients[J].Transplantation Proceedings,2009.2106-2108.
  • 10Kowalski R,Post D,Schneider MC. Immune cell function testing:an adjunct to therapeutic drug monitoring in transplant patient management[J].Clinical Transplantation,2003.77-88.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部